对动脉疾病的基因治疗.

Persistently increased expression of the transforming growth factor-β1 gene in human vascular restenosis: Analysis of 62 patients with one or more episode of restenosis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015

The de novo origin of the quiescent center regenerating root apices of Zea mays.

Planta·2014

Cytokinin biosynthesis in roots of corn.

Planta·2013

Light-induced inhibitors from intact and cultured caps of Zea roots.

Planta·2013

Light-regulated protein and mRNA synthesis in root caps of maize.

Plant molecular biology·2013

Abscisic acid, xanthoxin and violaxanthin in the caps of gravistimulated maize roots.

Planta·2013

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Microbiota-gut-brain axis imbalance: a promising therapeutic target for preserving brain health in high-altitude environment.

Frontiers in neuroscience·2026

A dual-prototype morphological topology evolution network for clinically oriented brain tumor MRI segmentation.

Frontiers in oncology·2026

Nose-to-brain delivery of candesartan-loaded nanoemulsion: brain biodistribution and neurobehavioral outcomes in controlled cortical impact-induced traumatic brain injury.

Inflammopharmacology·2026

Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.

International journal of pharmaceutics·2026

Design and in silico validation of donor DNA for RNA-guided recombinase-mediated knockout of mstnb gene in Labeo rohita.

PloS one·2026

Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study.

Cephalalgia : an international journal of headache·2026

相关实验视频

对动脉疾病的基因治疗.

相关概念视频

Persistently increased expression of the transforming growth factor-β1 gene in human vascular restenosis: Analysis of 62 patients with one or more episode of restenosis.

The de novo origin of the quiescent center regenerating root apices of Zea mays.

Cytokinin biosynthesis in roots of corn.

Light-induced inhibitors from intact and cultured caps of Zea roots.

Light-regulated protein and mRNA synthesis in root caps of maize.

Abscisic acid, xanthoxin and violaxanthin in the caps of gravistimulated maize roots.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Microbiota-gut-brain axis imbalance: a promising therapeutic target for preserving brain health in high-altitude environment.

A dual-prototype morphological topology evolution network for clinically oriented brain tumor MRI segmentation.

Nose-to-brain delivery of candesartan-loaded nanoemulsion: brain biodistribution and neurobehavioral outcomes in controlled cortical impact-induced traumatic brain injury.

Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.

Design and in silico validation of donor DNA for RNA-guided recombinase-mediated knockout of mstnb gene in Labeo rohita.

Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study.

相关实验视频

对动脉疾病的基因治疗.

相关概念视频

相关文章